Corteva (NYSE:CTVA) Given New $96.00 Price Target at The Goldman Sachs Group

Key Points

• The Goldman Sachs Group raised its price target on Corteva to $96 (from $88) and kept a "buy" rating, implying roughly a 14.89% upside from the prior close.
• Analyst coverage is mixed but overall positive: 14 analysts rate Corteva a Buy and 9 a Hold, giving a consensus "Moderate Buy" rating with a consensus price target of $83.95, which is well below Goldman's new target.
• Corteva reported quarterly EPS of $0.22 (meeting estimates) while revenue missed expectations, and the company set FY 2026 guidance at 3.450–3.700 EPS versus analysts' current-year estimate of about 2.96 EPS.

Corteva (NYSE:CTVA - Get Free Report) had its price target boosted by equities researchers at The Goldman Sachs Group from $88.00 to $96.00 in a research report issued to clients and investors on Tuesday,MarketScreener reports. The firm currently has a "buy" rating on the stock. The Goldman Sachs Group's target price indicates a potential upside of 14.89% from the company's previous close.

CTVA has been the subject of several other reports. Argus increased their price objective on shares of Corteva from $80.00 to $91.00 and gave the stock a "buy" rating in a research report on Tuesday, March 31st. Wall Street Zen lowered Corteva from a "buy" rating to a "hold" rating in a research report on Saturday, February 7th. Deutsche Bank Aktiengesellschaft boosted their price objective on Corteva from $85.00 to $90.00 and gave the company a "buy" rating in a research note on Thursday, February 5th. Royal Bank Of Canada upped their target price on Corteva from $80.00 to $89.00 and gave the company an "outperform" rating in a research report on Thursday, February 5th. Finally, Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Corteva in a research note on Monday, December 29th. Fourteen analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $83.95.

Corteva Stock Up 0.1%

Shares of NYSE:CTVA opened at $83.56 on Tuesday. The firm has a market cap of $56.10 billion, a P/E ratio of 52.78, a P/E/G ratio of 2.86 and a beta of 0.68. Corteva has a 12-month low of $58.58 and a 12-month high of $85.63. The business has a fifty day simple moving average of $78.94 and a 200 day simple moving average of $70.71. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA - Get Free Report) last issued its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, meeting the consensus estimate of $0.22. The company had revenue of $3.91 billion during the quarter, compared to analysts' expectations of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The business's quarterly revenue was down 1.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.32 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Analysts predict that Corteva will post 2.96 earnings per share for the current year.

Insider Buying and Selling at Corteva

In related news, insider Brian Titus sold 8,311 shares of Corteva stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $76.55, for a total transaction of $636,207.05. Following the transaction, the insider owned 8,090 shares of the company's stock, valued at $619,289.50. The trade was a 50.67% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.15% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Corteva

A number of hedge funds have recently bought and sold shares of CTVA. Annis Gardner Whiting Capital Advisors LLC increased its position in shares of Corteva by 9.1% during the 4th quarter. Annis Gardner Whiting Capital Advisors LLC now owns 1,674 shares of the company's stock valued at $112,000 after purchasing an additional 140 shares during the last quarter. Drive Wealth Management LLC boosted its stake in Corteva by 3.8% in the fourth quarter. Drive Wealth Management LLC now owns 4,259 shares of the company's stock valued at $285,000 after acquiring an additional 156 shares during the last quarter. Reynders McVeigh Capital Management LLC grew its position in shares of Corteva by 2.9% during the 4th quarter. Reynders McVeigh Capital Management LLC now owns 5,686 shares of the company's stock valued at $381,000 after acquiring an additional 160 shares during the period. Chesapeake Capital Corp IL grew its position in shares of Corteva by 0.9% during the 4th quarter. Chesapeake Capital Corp IL now owns 18,035 shares of the company's stock valued at $1,209,000 after acquiring an additional 161 shares during the period. Finally, Fox Run Management L.L.C. increased its stake in shares of Corteva by 5.1% during the 3rd quarter. Fox Run Management L.L.C. now owns 3,361 shares of the company's stock worth $227,000 after purchasing an additional 164 shares during the last quarter. 81.54% of the stock is owned by hedge funds and other institutional investors.

Corteva Company Profile

Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.